{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:01:41Z","timestamp":1791928901033,"version":"4.3.4"},"reference-count":43,"publisher":"Association for Research in Vision and Ophthalmology (ARVO)","issue":"14","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Invest. Ophthalmol. Vis. Sci."],"published-print":{"date-parts":[[2025,11,13]]},"DOI":"10.1167\/iovs.66.14.26","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T13:30:43Z","timestamp":1763040643000},"page":"26","source":"Crossref","is-referenced-by-count":5,"title":["GD2-CAR\u2013Engineered Microglia Exhibit Antitumor Effects in Organoids and Animal Models of Retinoblastoma"],"prefix":"10.1167","volume":"66","author":[{"given":"Jia","family":"Xu","sequence":"first","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yimeng","family":"Gao","sequence":"additional","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinyi","family":"Wang","sequence":"additional","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Lyv","sequence":"additional","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhibao","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youmin","family":"Cheng","sequence":"additional","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Bing","family":"Jin","sequence":"additional","affiliation":[{"name":"Beijing Institute of Ophthalmology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"27","reference":[{"issue":"15","key":"bib1","doi-asserted-by":"publisher","first-page":"1408","DOI":"10.1056\/NEJMra1803083","article-title":"Retinoblastoma origins and destinations","volume":"390","author":"Cobrinik","year":"2024","journal-title":"N Engl J Med"},{"issue":"6","key":"bib2","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1167\/iovs.66.6.65","article-title":"Optic nerve invasion in retinoblastoma: impact of eye salvage and adjuvant chemotherapy","volume":"66","author":"Feng","year":"2025","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"bib3","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1001\/jama.2023.0023","article-title":"Glioblastoma and other primary brain malignancies in adults: a review","volume":"329","author":"Schaff","year":"2023","journal-title":"JAMA"},{"issue":"6382","key":"bib4","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1126\/science.aar6711","article-title":"CAR T cell immunotherapy for human cancer","volume":"359","author":"June","year":"2018","journal-title":"Science"},{"key":"bib5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.canlet.2020.02.002","article-title":"Immunotherapy for glioma: current management and future application","volume":"476","author":"Xu","year":"2020","journal-title":"Cancer Lett"},{"issue":"1","key":"bib6","doi-asserted-by":"publisher","first-page":"7141","DOI":"10.1038\/s41467-024-51337-2","article-title":"CAR T-cell-mediated delivery of bispecific innate immune cell engagers for neuroblastoma","volume":"15","author":"Pascual-Pasto","year":"2024","journal-title":"Nat Commun"},{"issue":"10","key":"bib7","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/nbt.2678","article-title":"Generation of tumor-targeted human T lymphocytes from induced pluripotent stem cells for cancer therapy","volume":"31","author":"Themeli","year":"2013","journal-title":"Nat Biotechnol"},{"issue":"2","key":"bib8","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.stem.2018.06.002","article-title":"Human iPSC-derived natural killer cells engineered with chimeric antigen receptors enhance anti-tumor activity","volume":"23","author":"Li","year":"2018","journal-title":"Cell Stem Cell"},{"issue":"8","key":"bib9","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1038\/s41587-020-0462-y","article-title":"Human chimeric antigen receptor macrophages for cancer immunotherapy","volume":"38","author":"Klichinsky","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"1","key":"bib10","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1186\/s13045-020-00983-2","article-title":"Pluripotent stem cell-derived CAR-macrophage cells with antigen-dependent anti-cancer cell functions","volume":"13","author":"Zhang","year":"2020","journal-title":"J Hematol Oncol"},{"issue":"1","key":"bib11","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/s41590-023-01687-8","article-title":"A second-generation M1-polarized CAR macrophage with antitumor efficacy","volume":"25","author":"Lei","year":"2024","journal-title":"Nat Immunol"},{"issue":"4","key":"bib12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41408-021-00459-7","article-title":"CAR-T cell therapy: current limitations and potential strategies","volume":"11","author":"Sterner","year":"2021","journal-title":"Blood Cancer J"},{"issue":"9","key":"bib13","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1038\/s43018-023-00598-9","article-title":"Siglec-9 acts as an immune-checkpoint molecule on macrophages in glioblastoma, restricting T-cell priming and immunotherapy response","volume":"4","author":"Mei","year":"2023","journal-title":"Nat Cancer"},{"issue":"10","key":"bib14","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1158\/2159-8290.CD-18-0442","article-title":"Tumor antigen escape from CAR T-cell therapy","volume":"8","author":"Majzner","year":"2018","journal-title":"Cancer Discov"},{"issue":"12","key":"bib15","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nrd.2018.169","article-title":"Targeting macrophages: therapeutic approaches in cancer","volume":"17","author":"Cassetta","year":"2018","journal-title":"Nat Rev Drug Discov"},{"issue":"11","key":"bib16","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1038\/nrc3611","article-title":"Inflammation-induced cancer: crosstalk between tumours, immune cells and microorganisms","volume":"13","author":"Elinav","year":"2013","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"bib17","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov"},{"issue":"4","key":"bib18","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/nri.2017.125","article-title":"Microglia and macrophages in brain homeostasis and disease","volume":"18","author":"Li","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"bib19","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.cell.2019.08.053","article-title":"Microglia biology: one century of evolving concepts","volume":"179","author":"Prinz","year":"2019","journal-title":"Cell"},{"issue":"21","key":"bib20","doi-asserted-by":"publisher","first-page":"3458","DOI":"10.1016\/j.neuron.2022.10.020","article-title":"Microglia states and nomenclature: a field at its crossroads","volume":"110","author":"Paolicelli","year":"2022","journal-title":"Neuron"},{"issue":"1","key":"bib21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/nn.4185","article-title":"The role of microglia and macrophages in glioma maintenance and progression","volume":"19","author":"Hambardzumyan","year":"2016","journal-title":"Nat Neurosci"},{"issue":"1","key":"bib22","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s40478-024-01754-7","article-title":"Tumor associated microglia\/macrophages utilize GPNMB to promote tumor growth and alter immune cell infiltration in glioma","volume":"12","author":"Yalcin","year":"2024","journal-title":"Acta Neuropathol Commun"},{"issue":"7948","key":"bib23","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/s41586-022-05680-3","article-title":"Single-cell spatial immune landscapes of primary and metastatic brain tumours","volume":"614","author":"Karimi","year":"2023","journal-title":"Nature"},{"issue":"10","key":"bib24","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/s41583-018-0057-5","article-title":"Microglial signatures and their role in health and disease","volume":"19","author":"Butovsky","year":"2018","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"bib25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13024-019-0347-z","article-title":"Generating microglia from human pluripotent stem cells: novel in vitro models for the study of neurodegeneration","volume":"14","author":"Speicher","year":"2019","journal-title":"Mol Neurodegener"},{"issue":"6","key":"bib26","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1007\/s11427-021-2086-0","article-title":"Functional microglia derived from human pluripotent stem cells empower retinal organ","volume":"65","author":"Gao","year":"2022","journal-title":"Sci China Life Sci"},{"issue":"5","key":"bib27","doi-asserted-by":"publisher","first-page":"872","DOI":"10.1002\/glia.24507","article-title":"Enhanced innate responses in microglia derived from retinoblastoma patient-specific iPSCs","volume":"72","author":"Xu","year":"2024","journal-title":"Glia"},{"issue":"10","key":"bib28","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1038\/s43018-020-00119-y","article-title":"GD2-specific CAR T cells encapsulated in an injectable hydrogel control retinoblastoma and preserve vision","volume":"1","author":"Wang","year":"2020","journal-title":"Nat Cancer"},{"issue":"4","key":"bib29","doi-asserted-by":"publisher","first-page":"pgac162","DOI":"10.1093\/pnasnexus\/pgac162","article-title":"Second hit impels oncogenesis of retinoblastoma in patient-induced pluripotent stem cell-derived retinal organoids: direct evidence for Knudson's theory","volume":"1","author":"Li","year":"2022","journal-title":"PNAS Nexus"},{"issue":"571","key":"bib30","doi-asserted-by":"publisher","first-page":"eabd6169","DOI":"10.1126\/scitranslmed.abd6169","article-title":"Antitumor activity without on-target off-tumor toxicity of GD2-chimeric antigen receptor T cells in patients with neuroblastoma","volume":"12","author":"Straathof","year":"2020","journal-title":"Sci Transl Med"},{"issue":"52","key":"bib31","doi-asserted-by":"publisher","first-page":"33628","DOI":"10.1073\/pnas.2011780117","article-title":"Human embryonic stem cell-derived organoid retinoblastoma reveals a cancerous origin","volume":"117","author":"Liu","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"issue":"9","key":"bib32","doi-asserted-by":"publisher","first-page":"e005187","DOI":"10.1136\/jitc-2022-005187","article-title":"GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma","volume":"10","author":"Gargett","year":"2022","journal-title":"J Immunother Cancer"},{"key":"bib33","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/s41586-024-07242-1","article-title":"FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy","volume":"629","author":"Chan","year":"2024","journal-title":"Nature"},{"issue":"2","key":"bib34","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.neuron.2017.03.042","article-title":"iPSC-derived human microglia-like cells to study neurological diseases","volume":"94","author":"Abud","year":"2017","journal-title":"Neuron"},{"issue":"5","key":"bib35","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41571-020-00459-9","article-title":"Targeting cancer-promoting inflammation\u2014have anti-inflammatory therapies come of age?","volume":"18","author":"Hou","year":"2021","journal-title":"Nat Rev Clin Oncol"},{"key":"bib36","doi-asserted-by":"publisher","first-page":"100778","DOI":"10.1016\/j.preteyeres.2019.100778","article-title":"Innate immune response in retinal homeostasis and inflammatory disorders","volume":"74","author":"Murakami","year":"2020","journal-title":"Prog Retin Eye Res"},{"issue":"4","key":"bib37","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.immuni.2024.03.010","article-title":"Innate immune activation in neurodegenerative diseases","volume":"57","author":"Castro-Gomez","year":"2024","journal-title":"Immunity"},{"issue":"21","key":"bib38","doi-asserted-by":"publisher","first-page":"3497","DOI":"10.1016\/j.neuron.2022.10.005","article-title":"The CNS mononuclear phagocyte system in health and disease","volume":"110","author":"Mundt","year":"2022","journal-title":"Neuron"},{"issue":"6","key":"bib39","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1016\/j.stem.2025.03.009","article-title":"Harnessing human iPSC-microglia for CNS-wide delivery of disease-modifying proteins","volume":"32","author":"Chadarevian","year":"2025","journal-title":"Cell Stem Cell"},{"key":"bib40","doi-asserted-by":"publisher","first-page":"1371345","DOI":"10.3389\/fimmu.2024.1371345","article-title":"GD2-targeting therapy: a comparative analysis of approaches and promising directions","volume":"15","author":"Philippova","year":"2024","journal-title":"Front Immunol"},{"issue":"8047","key":"bib41","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1038\/s41586-024-08261-8","article-title":"Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers","volume":"637","author":"Steffin","year":"2025","journal-title":"Nature"},{"issue":"21","key":"bib42","doi-asserted-by":"publisher","first-page":"e175824","DOI":"10.1172\/JCI175824","article-title":"FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI\/ML-based approaches","volume":"133","author":"Zushin","year":"2023","journal-title":"J Clin Invest"},{"issue":"8","key":"bib43","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1056\/NEJMoa2308917","article-title":"CD19 CAR T-cell therapy in autoimmune disease\u2014a case series with follow-up","volume":"390","author":"M\u00fcller","year":"2024","journal-title":"N Engl J Med"}],"container-title":["Investigative Ophthalmology & Visual Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2811075","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T21:32:01Z","timestamp":1791927121000},"score":1,"resource":{"primary":{"URL":"https:\/\/iovs.arvojournals.org\/article.aspx?articleid=2811075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":43,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2025,11,3]]}},"URL":"https:\/\/doi.org\/10.1167\/iovs.66.14.26","relation":{},"ISSN":["1552-5783"],"issn-type":[{"value":"1552-5783","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11,13]]}}}